Project Start
1993-06-30
Project End
2003-06-29
Budget Start
1999-02-08
Budget End
2003-06-29
Support Year
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Alexis, Neil E; Eldridge, Marlowe W; Peden, David B (2003) Effect of inhaled endotoxin on airway and circulating inflammatory cell phagocytosis and CD11b expression in atopic asthmatic subjects. J Allergy Clin Immunol 112:353-61
Robbins, W A; Witt, K L; Haseman, J K et al. (2001) Antiretroviral therapy effects on genetic and morphologic end points in lymphocytes and sperm of men with human immunodeficiency virus infection. J Infect Dis 184:127-35
Eldridge, M W; Peden, D B (2000) Allergen provocation augments endotoxin-induced nasal inflammation in subjects with atopic asthma. J Allergy Clin Immunol 105:475-81
Eldridge, M W; Peden, D B (2000) Airway response to concomitant exposure with endotoxin and allergen in atopic asthmatics. J Toxicol Environ Health A 61:27-37
Coffey, C S; Muller, K E (1999) Exact test size and power of a Gaussian error linear model for an internal pilot study. Stat Med 18:1199-214
Shea, K M; Farrow, A; Little, R (1997) An investigation of the effect of paternal occupation group at conception on birth weight and gestational age. ALSPAC Study Team of Pregnancy and Childhood. Am J Ind Med 31:738-43
Warshauer, D M; Wehmueller, M D; Molina, P L et al. (1997) Hepatic enhancement and metastatic lesion conspicuity on CT scans: influence of intravenous glucagon and oral CT contrast material. Radiology 202:394-8
Shea, K M; Little, R E (1997) Is there an association between preconception paternal x-ray exposure and birth outcome? The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. Am J Epidemiol 145:546-51
Zeldin, D C; Foley, J; Ma, J et al. (1996) CYP2J subfamily P450s in the lung: expression, localization, and potential functional significance. Mol Pharmacol 50:1111-7